349 related articles for article (PubMed ID: 16304886)
21. [What is new in the treatment of community-acquired pneumonia?].
Welte T; Marre R; Suttorp N;
Med Klin (Munich); 2006 Apr; 101(4):313-20. PubMed ID: 16607488
[TBL] [Abstract][Full Text] [Related]
22. [Optimisation of the antibiotic policy in the Netherlands. X. The SWAB guideline for antimicrobial treatment of complicated urinary tract infections].
Geerlings SE; van den Broek PJ; van Haarst EP; Vleming LJ; van Haaren KM; Janknegt R; Platenkamp GJ; Prins JM
Ned Tijdschr Geneeskd; 2006 Oct; 150(43):2370-6. PubMed ID: 17100128
[TBL] [Abstract][Full Text] [Related]
23. Empiric treatment in hospitalized community-acquired pneumonia. Impact on mortality, length of stay and re-admission.
Reyes Calzada S; Martínez Tomas R; Cremades Romero MJ; Martínez Moragón E; Soler Cataluña JJ; Menéndez Villanueva R
Respir Med; 2007 Sep; 101(9):1909-15. PubMed ID: 17628462
[TBL] [Abstract][Full Text] [Related]
24. Impact of guideline-concordant empiric antibiotic therapy in community-acquired pneumonia.
Frei CR; Restrepo MI; Mortensen EM; Burgess DS
Am J Med; 2006 Oct; 119(10):865-71. PubMed ID: 17000218
[TBL] [Abstract][Full Text] [Related]
25. The role of new therapies for severe community-acquired pneumonia.
Restrepo MI; Anzueto A
Curr Opin Infect Dis; 2006 Dec; 19(6):557-64. PubMed ID: 17075331
[TBL] [Abstract][Full Text] [Related]
26. Audit of the management of patients admitted with community acquired pneumonia.
Foley SC; Kelly EM; O'Neill SJ
Ir Med J; 2006 May; 99(5):138-40. PubMed ID: 16892917
[TBL] [Abstract][Full Text] [Related]
27. New guidelines for the management of adult community-acquired pneumonia.
Armitage K; Woodhead M
Curr Opin Infect Dis; 2007 Apr; 20(2):170-6. PubMed ID: 17496576
[TBL] [Abstract][Full Text] [Related]
28. Evidence-based emergency medicine/critically appraised topic. Evidence behind the 4-hour rule for initiation of antibiotic therapy in community-acquired pneumonia.
Yu KT; Wyer PC
Ann Emerg Med; 2008 May; 51(5):651-62, 662.e1-2. PubMed ID: 18272253
[TBL] [Abstract][Full Text] [Related]
29. [Basis and guidelines for empirical antibody therapy in the management of community-acquired pneumonia].
Louzir B; Beji M; Fajraoui N; Mehiri N; Daghfous J
Tunis Med; 2001 Oct; 79(10):491-7. PubMed ID: 11910687
[TBL] [Abstract][Full Text] [Related]
30. Tailored interventions to improve antibiotic use for lower respiratory tract infections in hospitals: a cluster-randomized, controlled trial.
Schouten JA; Hulscher ME; Trap-Liefers J; Akkermans RP; Kullberg BJ; Grol RP; van der Meer JW
Clin Infect Dis; 2007 Apr; 44(7):931-41. PubMed ID: 17342644
[TBL] [Abstract][Full Text] [Related]
31. [Community acquired pneumonia; no reason to revise current Dutch antibiotic guidelines].
Oosterheert JJ; Bonten MJ; Schneider MM; Hoepelman IM
Ned Tijdschr Geneeskd; 2003 Mar; 147(9):381-6. PubMed ID: 12661455
[TBL] [Abstract][Full Text] [Related]
32. [Anglo-Saxon guidelines for the treatment of community-acquired pneumonia applicable in The Netherlands as well].
Hoepelman IM; Sachs AP; Visser MR; Lammers JW
Ned Tijdschr Geneeskd; 1997 Aug; 141(33):1597-601. PubMed ID: 9543764
[TBL] [Abstract][Full Text] [Related]
33. Current treatment of community-acquired pneumonia.
Liapikou A; Torres A
Expert Opin Pharmacother; 2013 Jul; 14(10):1319-32. PubMed ID: 23663104
[TBL] [Abstract][Full Text] [Related]
34. Antibiotics for community-acquired pneumonia.
Dryden M; Hand K; Davey P;
J Antimicrob Chemother; 2009 Dec; 64(6):1123-5. PubMed ID: 19820250
[TBL] [Abstract][Full Text] [Related]
35. Therapy in pneumonia: what is beyond antibiotics?
Meijvis SC; Grutters JC; Thijsen SF; Rijkers GT; Biesma DH; Endeman H
Neth J Med; 2011 Jan; 69(1):21-6. PubMed ID: 21325697
[TBL] [Abstract][Full Text] [Related]
36. Antibiotic therapy of hospitalized patients with community-acquired pneumonia: an international perspective from the CAPO Cohort Study.
Peyrani P; Christensen D; LaJoie AS; Nakamatsu R; Arnold F; Schulz P; Toala I; Ramirez A; Lobo S; Johnson B; Chesnut D; Richmond B; De La Cruz R; Carrico R; Ramirez J;
J Ky Med Assoc; 2006 Nov; 104(11):513-7. PubMed ID: 17175853
[TBL] [Abstract][Full Text] [Related]
37. Comparative study of levofloxacin in the treatment of children with community-acquired pneumonia.
Bradley JS; Arguedas A; Blumer JL; Sáez-Llorens X; Melkote R; Noel GJ
Pediatr Infect Dis J; 2007 Oct; 26(10):868-78. PubMed ID: 17901791
[TBL] [Abstract][Full Text] [Related]
38. Advances in antibiotic therapy for community-acquired pneumonia.
Viasus D; Garcia-Vidal C; Carratalà J
Curr Opin Pulm Med; 2013 May; 19(3):209-15. PubMed ID: 23422416
[TBL] [Abstract][Full Text] [Related]
39. Guideline-concordant therapy and reduced mortality and length of stay in adults with community-acquired pneumonia: playing by the rules.
McCabe C; Kirchner C; Zhang H; Daley J; Fisman DN
Arch Intern Med; 2009 Sep; 169(16):1525-31. PubMed ID: 19752411
[TBL] [Abstract][Full Text] [Related]
40. Management of community-acquired pneumonia by trained family general practitioners.
Potena A; Simoni M; Cellini M; Cartabellotta A; Ballerin L; Piattella M; Putinati S
Int J Tuberc Lung Dis; 2008 Jan; 12(1):19-25. PubMed ID: 18173872
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
